Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population

Autor: Chi Huang, Li Yang, Chao Yang, Xiangkun Huan, Hao Fan, Younan Wang, Zekuan Xu, Dakui Luo
Rok vydání: 2016
Předmět:
Adult
Male
0301 basic medicine
Oncology
medicine.medical_specialty
Genotype
medicine.medical_treatment
Single-nucleotide polymorphism
Liver transplantation
Polymerase Chain Reaction
Polymorphism
Single Nucleotide

Tripartite Motif Proteins
03 medical and health sciences
0302 clinical medicine
Asian People
Risk Factors
Stomach Neoplasms
Polymorphism (computer science)
Internal medicine
Metalloproteins
synonymous variant
medicine
Humans
Genetic Predisposition to Disease
TRIM59
International HapMap Project
Allele
Aged
Genetics
business.industry
gastric cancer
Intracellular Signaling Peptides and Proteins
Membrane Proteins
Cancer
Heterozygote advantage
Middle Aged
medicine.disease
030104 developmental biology
Case-Control Studies
030220 oncology & carcinogenesis
Female
Chinese population
business
Research Paper
Zdroj: Oncotarget
ISSN: 1949-2553
DOI: 10.18632/oncotarget.14075
Popis: // Dakui Luo 1, * , Younan Wang 1, * , Xiangkun Huan 1, * , Chi Huang 1, * , Chao Yang 2 , Hao Fan 1 , Zekuan Xu 1 , Li Yang 1 1 Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China 2 Liver Transplantation Center of the First Affiliated Hospital and Key Laboratory on Living Donor Liver Transplantation, Ministry of Health, Nanjing Medical University, Nanjing, Jiangsu, China * These authors have contributed equally to this work Correspondence to: Li Yang, email: pwkyangli@163.com Keywords: gastric cancer, TRIM59, synonymous variant, genotype, Chinese population Received: July 13, 2016 Accepted: November 22, 2016 Published: December 21, 2016 ABSTRACT Tripartite motif 59 (TRIM59) is a novel oncogenic driver in gastric cancer (GC) that is implicated in disease progression as well as dismal survival. Genetic variants in peculiar gene are likely candidates for conferring hereditary susceptibility. The role of TRIM59 polymorphism in predicting the risk of malignant diseases and its relevance to TRIM59 expression have not been discussed. Using a HapMap tagSNPs approach, we screened three tag TRIM59 single nucleotide polymorphisms (SNPs) (rs1141023G>A, rs7629A>G, rs11706810T>C) which were genotyped in 602 GC patients and 868 healthy controls. Our study provided convincing result that carries of variant rs1141023A allele markedly increased GC risk (P=0.006). In comparison with the GG homozygotes, the variant GA heterozygotes demonstrated 1.50-fold elevated risk of GC (p=0.014, 95% confidence interval [CI] = 1.09–2.08). Subjects who carried the (GA+AA) genotypes of rs1141023 were associated with remarkable increased GC risk compared with the common genotype (P = 0.013, adjusted OR = 1.50, 95% CI = 1.09–2.05). Further stratified analyses displayed that the relationship between mutant genotype of rs1141023 and GC risk was more profound in male individuals. Intriguingly, there is no significant distinction of TRIM59 mRNA expression between rs1141023GA genotype and GG genotype in 44 normal gastric tissues. Taken together, our results suggest that rs1141023 polymorphism contributes to increased predisposition to GC and thus may be responsible for predicting early GC.
Databáze: OpenAIRE